Funded Tech Companies
Abcuro
Headquartered in Newton, Abcuro has funding from BlackRock, Soleus Capital and Tekla Capital Management.
Company Overview
Company Name
Abcuro
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
90 Bridge St. 100
Newton, MA 02458
USA
Newton, MA 02458
USA
Phone
Website
Email Address
Company Background Information
Overview
We are developing first-in-class immunotherapies for autoimmune diseases and cancer through precise elimination or modulation of cytotoxic T and NK cells via KLRG1. We believe this strategy will result in therapeutics with reduced toxicity compared to existing therapeutic approaches for T cell modulation.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
8/18/2023
Financing History
Management Team
Title
Name
Email & Social
Chairman
Steven Greenberg
Chief Executive Officer
David de Graaf
Chief Financial Officer
David Neafus
Chief Medical Officer
Richard Polisson
Chief Operating Officer
Evan Thompson
Chief Scientific Officer
Stefano Gulla
Company Investors
- BlackRock
- Soleus Capital
- Tekla Capital Management
- New Leaf Venture Partners
- Sanofi Ventures
- Mass General Brigham Ventures
- RA Capital Management
- Bain Capital Life Sciences
- Samsara BioCapital (Donald McCarthy)
- Pontifax Venture Capital
- Eurofarma
- Redmile Group
- Sanofi-Genzyme BioVentures (Jason Hafler)
- Pontifax Fund (Iyona Rajkomar)
- Hongsen Investment (Yajun Xu)
- RA Capital (Ryan Berry)
- Mass General Brigham Innovation (Julius Knowles)
Browse more funded tech companies:
abCoffee | Abdera Therapeutics
Share this article
About Our VC Deals Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs